VC  Versant Ventures

http://www.versantventures.com





     Office Locations:

3000 Sand Hill Road, Bldg. 4, Ste. 210
Menlo Park, CA 94025
Phone: 650-233-7877
Fax: 650-854-9513

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1999, Versant Ventures currently manages over $1.9 billion in committed capital having recently raised its fifth fund. The firm specializes in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. Versant seeks large market opportunities and will not invest in a new company unless the opportunity has at least $500 million in annualized potential in the U.S. Versant has and will occasionally invest in later stage companies with the right attributes. Initial investments have been as small as $250 thousand and total investments have been as large as $30 million. The firm announced December of 2014 the close of Versant Venture Capital V L.P. at $305 million and in excess of the initial fund target of $250 million.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Alex Mayweg PhD Partner
    Barbara Lubash PhD Managing Director
    Brad Bolzon PhD Managing Director, Chairman
    Brian Atwood Managing Director
    Carlo Rizzutto PhD Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/29/2018


      Tempest Therapeutics


      CA


      $70,000,000


      Series B


      02/28/2018


      Quentis Therapeutics


      NY


      $48,000,000


      Series A


      01/18/2018


      Pandion Therapeutics


      MA


      $58,000,000


      Series A


      01/08/2018


      Intuity Medical


      CA


      $70,000,000


      


      12/15/2017


      Jnana Therapeutics


      MA


      $50,000,000


      Series A


      11/08/2017


      Oyster Point Pharmaceuticals


      CA


      $22,000,000


      Series A


      09/07/2017


      Gritstone Oncology


      CA


      $92,700,000


      Series B


      07/26/2017


      VenatoRx Pharmaceuticals


      PA


      $42,000,000


      Series B


      07/25/2017


      Sebacia


      GA


      $20,000,000


      Series D


     

    Portfolio companies include:


      AAVLife
        web link


      Achaogen
        web link


      Audentes Therapeutics
        web link


      Benvenue Medical
        web link


      CardiAQ Valve Technologies
        web link


      Cereve
        web link


      Ceterix Orthopaedics
        web link


      Crinetics Pharmaceuticals
        web link


      Flexion Therapeutics
        web link


      ForSight Vision5
        web link


      Gritstone Oncology
        web link


      Holaira
        web link


      Homestead Clinical
        web link


      Immune Design
        web link


      Inari Medical
        web link


      Intuity Medical
        web link


      ISB Accelerator
        web link


      Jnana Therapeutics
        web link


      Kinestral Technologies
        web link


      Kythera Biopharmaceuticals
        web link


      Laguna Pharmaceuticals
        web link


      Metabolex
        web link


      Mirina
        web link


      Monteris Medical
        web link


      NeuWave Medical
        web link


      Novira Therapeutics
        web link


      Ocular Therapeutix
        web link


      Okairos
        web link


      OpGen
        web link


      Oyster Point Pharmaceuticals
        web link


      Pandion Therapeutics
        web link


      Pathwork Diagnostics
        web link


      PhaseRx
        web link


      Phenomix
        web link


      Quanticel
        web link


      Quentis Therapeutics
        web link


      Repare Therapeutics
        web link


      ROX Medical
        web link


      RuiYi
        web link


      Sebacia
        web link


      Semprae Laboratories
        web link


      Sentient Pharmaceuticals
        web link


      Sequent Medical
        web link


      Seredigm
        web link


      Spark Diagnostics
        web link


      Synosia Therapeutics
        web link


      Tempest Therapeutics
        web link


      Theraclone Sciences
        web link


      VenatoRx Pharmaceuticals
        web link


      Veracyte
        web link


      Veran Medical Technologies
        web link


      VerCo
        web link


      Viral Logic Systems Technology
        web link


      WaveTec Vision
        web link


      Zyga Technology
        web link


     

    Recent News: